<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>40</patient-age><report-id>US-PFIZER INC-2013001311</report-id><gender>female</gender><reactions><reaction>muscle pain</reaction><reaction>pain in upper chest (in the right side) and left back area/ right chest and left upper back</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Lipitor</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>High cholesterol</indication></indications><patient-age>40</patient-age><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254124_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151551</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2013001311</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="2">No</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-02</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-23</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2013001311</companynumb>
		<primarysource>
			<reportergivename>Sue</reportergivename>
			<reporterfamilyname>Beal</reporterfamilyname>
			<reporterstreet>Pfizer 4300 Oak Park</reporterstreet>
			<reportercity>Sanford</reportercity>
			<reporterstate>NC</reporterstate>
			<reporterpostcode>27330</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientonsetage>40</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex code="2">Female</patientsex>
			<reaction>
				<primarysourcereaction>muscle pain</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Muscle pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Myalgia</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>pain in upper chest (in the right side) and left back area/ right chest and left upper back</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Chest pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Chest pain</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>pain in upper chest (in the right side) and left back area/ right chest and left upper back</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Back pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Back pain</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Lipitor</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>20-702</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugdosagetext>UNK</drugdosagetext>
				<drugdosageform normalized="film-coated tablet">Film-coated tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>High cholesterol</drugindication>
				<drugstartdateformat>610</drugstartdateformat>
				<drugstartdate>2012-10-01</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>ATORVASTATIN CALCIUM</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Back pain</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Back pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Chest pain</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Chest pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscle pain</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscle pain</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from a contactable <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>(Pfizer employee) who reported for her colleague. A 40-year old <Semaphore x="2699001" class="Race" value="White" score="1.00" ID="C41261">Caucasian </Semaphore>female patient started to receive <Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium </Semaphore></Semaphore>(<Semaphore x="791535" class="Medicine" value="Lipitor" score="0.74" ID="239689">LIPITOR</Semaphore>) <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">orally </Semaphore>in Oct2012 at an unknown <Semaphore x="1863371" class="Procedure" value="Dose Frequency" score="1.00" ID="C89081">dose and frequency </Semaphore>for <Semaphore x="2036179" class="Disease or Finding" value="Hypercholesterolemia" score="1.00" ID="C37967">high cholesterol</Semaphore>. The relevant medical history and concomitant medication were unknown. It was reported that since an unknown date, the patient started experiencing <Semaphore x="2246514" class="AnatomicStructure" value="Muscle Tissue" score="1.00" ID="C12435">muscle </Semaphore><Semaphore x="2365183" class="Disease or Finding" value="Pain" score="1.00" ID="C3303">pain </Semaphore>and <Semaphore x="1761238" class="Disease or Finding" value="Chest Pain" score="1.00" ID="C38665">pain in upper chest </Semaphore>(in the right side) and left <Semaphore x="1563494" class="AnatomicStructure" value="Back" score="1.00" ID="C13062">back </Semaphore>area, described on 23Jan2013 as right <Semaphore x="1762050" class="AnatomicStructure" value="Chest" score="1.00" ID="C25389">chest </Semaphore>and left upper <Semaphore x="1563494" class="AnatomicStructure" value="Back" score="1.00" ID="C13062">back</Semaphore>, while on <Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium</Semaphore></Semaphore>. As of 23Jan2013, it was reported that the patient was not hospitalized and did not die. The relevant laboratory data was unknown. The patient was still taking <Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium </Semaphore></Semaphore>but as of 23Jan2013, it was reported that the patient was going to follow up with her <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">doctor</Semaphore>. Therapeutic measures taken for the reported events were unknown. Clinical <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the reported events was unknown. As of 23Jan2013, the reporter reported that the patient did provide information to her regarding the reported <Semaphore x="2724216" class="MedDRA LLT" value="Adverse event" score="1.00" ID="10060933">adverse events </Semaphore>with the use of the product but could not confirm the occurrence of the events reported by the patient.Follow up (23Jan2013): New information from the same contactable <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>included: suspect <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>data (<Semaphore x="169912" class="Medicine" value="Atorvastatin calcium" score="0.93" ID="286842">atorvastatin <Semaphore x="1670132" class="Procedure" value="Calcium Measurement" score="1.00" ID="C64488">calcium </Semaphore></Semaphore>(<Semaphore x="791535" class="Medicine" value="Lipitor" score="0.74" ID="239689">LIPITOR</Semaphore>) route of administration) and course of events description.Follow up attempts completed. No further information expected.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>